HRI provides tools to assess national harm reduction investment and spending on drug law enforcement in seven Asian countries and insights on the state of harm reduction financing by donors and governments, civil society and community representatives.
Bouso & Sánchez-Avilés argue that indigenous epistemologies should be respected and protected within the frameworks of the right to science and the right to health, in compliance with international treaties and United Nations declarations.
Chang et al. call for an end to the criminalisation of drug use and the enactment of a new reality based on solidarity and cooperation, to protect the health and restore of the rights and dignity of people who use drugs.
The Ana Liffey Drug Project and the LSE shed light on the positive impact of pragmatic, comprehensive and tailored responses to the challenges posed by the COVID-19 pandemic, particularly for people in situations of vulnerability.
The survey identifies a range of issues such as the access to health and harm reduction services and the ongoing negative impact of criminalisation, stigma and discrimination on the lives of people who use drugs.
IDPC and TNI argue that the WHO’s recommendations will be an opportunity for African States to further decolonise drug control and strengthen the legal basis for emerging medicinal cannabis programmes.